Healthcare · Pharmaceuticals & Biotechnology
QVM read Cheap on its own multiples Quality Weak, Valuation Undervalued, Momentum Bearish
Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.
Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.
PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.
Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.
Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.
Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).
Ranks #153 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.
| Filed | Person | Category | Type | Quantity | Value |
|---|---|---|---|---|---|
| 10 Apr 2026 | SHREE KISHORIJU TRADING AND INVESTMENT PRIVATE LIMITED | Promoter | Pledge Revoke | 0 | ₹51,465 |
| 20 Mar 2026 | AJAY RAMNIWAS DHOOT | Promoter group | Pledge Revoke | 0 | ₹0 |
| 20 Mar 2026 | SHREE RASBIHARI TRADING AND INVESTMENTS PRIVATE LIMITED | Promoter | Pledge Revoke | 0 | ₹54.86 L |
| 20 Mar 2026 | ADITYA RAMNIWAS DHOOT | Promoter group | Pledge Revoke | 0 | ₹0 |
| 27 Feb 2026 | SHREE KISHORIJU TRADING AND INVESTMENTS PRIVATE LIMITED | Promoter | Pledge Revoke | 0 | ₹33.05 L |
| 8 Dec 2025 | SHRI JB PHARMA PRIVATE LIMITED | Promoter group | Pledge Invoke | 0 | ₹6.20 Cr |
| 3 Dec 2025 | SHREE KISHORIJU TRADING AND INVESTMENTS PRIVATE LIMITED | Promoter | Pledge Invoke | 0 | ₹2.15 Cr |
| 3 Dec 2025 | SHREE RASBIHARI TRADING AND INVESTMENTS PVT LTD | Promoter | Pledge Invoke | 0 | ₹8.60 L |
| 28 Nov 2025 | SHREE KISHORIJU TRADING AND INVESTMENTS PRIVATE LIMITED | Promoter | Pledge Invoke | 0 | ₹2.24 Cr |
| 13 Nov 2025 | SHREE KISHORIJU TRADING AND INVESTMENTS PRIVATE LIMITED | Promoter | Pledge | 0 | ₹66.90 L |
| Date | Client | Deal | Action | Quantity | Price | Exchange |
|---|---|---|---|---|---|---|
| 3 Feb 2026 | NEO APEX VENTURE LLP | Bulk | Sell | 350,000 | 37.9000 | NSE |
| 3 Feb 2026 | NEO APEX VENTURE LLP | Bulk | Sell | 105,753 | 38.0100 | BSE |
| 2 Feb 2026 | NEO APEX VENTURE LLP | Bulk | Buy | 455,753 | 32.6800 | NSE |
| 13 Jan 2026 | SANJAY KUMAR SAINI | Bulk | Sell | 95,000 | 40.6500 | NSE |
| 13 Jan 2026 | JYOTIPRASAD TAPARIA | Bulk | Sell | 150,000 | 42.6400 | NSE |
| 12 Jan 2026 | SHIVKUMAR DAMANI | Bulk | Sell | 81,999 | 40.6100 | NSE |
| 12 Jan 2026 | ASHUTOSH TAPARIA | Bulk | Sell | 200,000 | 40.6100 | NSE |
| 9 Jan 2026 | SANJAY KUMAR SAINI | Bulk | Buy | 95,000 | 38.7700 | BSE |
| 9 Jan 2026 | EPITOME TRADING AND INVESTMENTS | Bulk | Sell | 134,064 | 38.7700 | BSE |
| 8 Jan 2026 | EPITOME TRADING AND INVESTMENTS | Bulk | Buy | 100,000 | 36.8400 | NSE |
| Ex-date | Subject | Per share (₹) | Record date |
|---|---|---|---|
| 21 Dec 2017 | Interim Dividend Re 0.50 Per Share | 0.5000 | 22 Dec 2017 |
| 30 Aug 2005 | Agm/Dividend-2% | — | — |
Bonuses, splits, buybacks and other events. Dividends are listed separately above.
| Ex-date | Type | Subject |
|---|---|---|
| 17 Sep 2018 | OTHER | Annual General Meeting |
| 18 Sep 2017 | OTHER | Annual General Meeting |
| 22 Sep 2016 | OTHER | Annual General Meeting (Book Closure Dates Revised) |
| 26 Aug 2015 | OTHER | Annual General Meeting |
| 18 Sep 2014 | OTHER | Annual General Meeting |
Quarterly results, AGMs, buybacks and other board-approved business.
| Date | Purpose | Results |
|---|---|---|
| 12 Aug 2026 | Financial Results/Other business matters | Yes |
| 14 May 2026 | Financial Results/Other business matters | Yes |
| 26 Mar 2026 | Other business matters | — |
| 6 Feb 2026 | Other business matters | — |
| 15 Jan 2026 | Financial Results | Yes |
Exchange disclosures (NSE and BSE), most recent first.
| Date | Category | Announcement |
|---|---|---|
| 3 Oct 2026 | Company Update | Mangalam Drugs & Organics Ltd - 532637 - Announcement under Regulation 30 (LODR)-Newspaper Publication |
| 3 Oct 2026 | Copy of Newspaper Publication | Mangalam Drugs And Organics Limited has informed the Exchange about Copy of Newspaper Publication |
| 1 Oct 2026 | AGM/EGM | Mangalam Drugs & Organics Ltd - 532637 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot |
| 1 Oct 2026 | Shareholders meeting | Mangalam Drugs And Organics Limited has informed the Exchange regarding Notice of Postal Ballot |
| 28 Sep 2026 | Others | Mangalam Drugs & Organics Ltd - 532637 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A |
| 25 Sep 2026 | Insider Trading / SAST | Mangalam Drugs & Organics Ltd - 532637 - Closure of Trading Window |
| 25 Sep 2026 | Trading Window | Mangalam Drugs And Organics Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| 24 Sep 2026 | Appointment | Mangalam Drugs And Organics Limited has informed the Exchange regarding Appointment of S.N Nanda & Co. (FRN: 000685N) as Other of the company w.e.f. September 23, 2026. |
| 24 Sep 2026 | Retirement | Mangalam Drugs And Organics Limited has informed the Exchange about Retirement |
| 24 Sep 2026 | Change in Management | Mangalam Drugs And Organics Limited has informed the Exchange about change in Management |
Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.
Data unavailable.
Board of directors and corporate information →
Data unavailable (no single-stock futures or options activity on record for this company).
The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.
The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.
The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.
No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.
